89 related articles for article (PubMed ID: 19956892)
1. Association of the ABCB1 3435C>T polymorphism and treatment outcomes in advanced gastric cancer patients treated with paclitaxel-based chemotherapy.
Chang H; Rha SY; Jeung HC; Im CK; Noh SH; Kim JJ; Chung HC
Oncol Rep; 2010 Jan; 23(1):271-8. PubMed ID: 19956892
[TBL] [Abstract][Full Text] [Related]
2. The polymorphisms of TS and MTHFR predict survival of gastric cancer patients treated with fluorouracil-based adjuvant chemotherapy in Chinese population.
Huang ZH; Hua D; Li LH
Cancer Chemother Pharmacol; 2009 Apr; 63(5):911-8. PubMed ID: 18704422
[TBL] [Abstract][Full Text] [Related]
3. ABCB1, FCGR2A, and FCGR3A polymorphisms in patients with HER2-positive metastatic breast cancer who were treated with first-line taxane plus trastuzumab chemotherapy.
Kim JW; Kim JH; Im SA; Kim YJ; Han HS; Kim JS; Han SW; Jeon YK; Oh DY; Han W; Kim TY; Park IA; Noh DY; Bang YJ
Oncology; 2012; 83(4):218-27. PubMed ID: 22906996
[TBL] [Abstract][Full Text] [Related]
4. Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapy.
Shitara K; Matsuo K; Ito S; Sawaki A; Kawai H; Yokota T; Takahari D; Shibata T; Ura T; Ito H; Hosono S; Kawase T; Watanabe M; Tajima K; Yatabe Y; Tanaka H; Muro K
Asian Pac J Cancer Prev; 2010; 11(2):447-52. PubMed ID: 20843132
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer.
Graziano F; Ruzzo A; Santini D; Humar B; Tonini G; Catalano V; Berardi R; Pizzagalli F; Arduini F; Bearzi I; Scartozzi M; Cascinu S; Testa E; Ficarelli R; Magnani M
J Clin Oncol; 2005 Apr; 23(10):2339-45. PubMed ID: 15800325
[TBL] [Abstract][Full Text] [Related]
6. TP53 codon 72 polymorphism associated with prognosis in patients with advanced gastric cancer treated with paclitaxel and cisplatin.
Kim JG; Sohn SK; Chae YS; Song HS; Kwon KY; Do YR; Kim MK; Lee KH; Hyun MS; Lee WS; Sohn CH; Jung JS; Kim GC; Chung HY; Yu W
Cancer Chemother Pharmacol; 2009 Jul; 64(2):355-60. PubMed ID: 19052714
[TBL] [Abstract][Full Text] [Related]
7. Association of drug transporter gene ABCB1 (MDR1) 3435C to T polymorphism with colchicine response in familial Mediterranean fever.
Tufan A; Babaoglu MO; Akdogan A; Yasar U; Calguneri M; Kalyoncu U; Karadag O; Hayran M; Ertenli AI; Bozkurt A; Kiraz S
J Rheumatol; 2007 Jul; 34(7):1540-4. PubMed ID: 17610314
[TBL] [Abstract][Full Text] [Related]
8. Paclitaxel and leucovorin-modulated infusional 5-fluorouracil combination chemotherapy for metastatic gastric cancer.
Cho BC; Kim JH; Kim CB; Sohn JH; Choi HJ; Lee YC; Ahn JB
Oncol Rep; 2006 Mar; 15(3):621-7. PubMed ID: 16465422
[TBL] [Abstract][Full Text] [Related]
9. ABCB1 (MDR 1) polymorphisms and progression-free survival among women with ovarian cancer following paclitaxel/carboplatin chemotherapy.
Johnatty SE; Beesley J; Paul J; Fereday S; Spurdle AB; Webb PM; Byth K; Marsh S; McLeod H; ; Harnett PR; Brown R; DeFazio A; Chenevix-Trench G
Clin Cancer Res; 2008 Sep; 14(17):5594-601. PubMed ID: 18765553
[TBL] [Abstract][Full Text] [Related]
10. Association of ABCB1 genetic variants 3435C>T and 2677G>T to ABCB1 mRNA and protein expression in brain tissue from refractory epilepsy patients.
Mosyagin I; Runge U; Schroeder HW; Dazert E; Vogelgesang S; Siegmund W; Warzok RW; Cascorbi I
Epilepsia; 2008 Sep; 49(9):1555-61. PubMed ID: 18494787
[TBL] [Abstract][Full Text] [Related]
11. Pharmacogenetic profiling and clinical outcome of patients with advanced gastric cancer treated with palliative chemotherapy.
Ruzzo A; Graziano F; Kawakami K; Watanabe G; Santini D; Catalano V; Bisonni R; Canestrari E; Ficarelli R; Menichetti ET; Mari D; Testa E; Silva R; Vincenzi B; Giordani P; Cascinu S; Giustini L; Tonini G; Magnani M
J Clin Oncol; 2006 Apr; 24(12):1883-91. PubMed ID: 16622263
[TBL] [Abstract][Full Text] [Related]
12. Polymorphisms in p53, GSTP1 and XRCC1 predict relapse and survival of gastric cancer patients treated with oxaliplatin-based adjuvant chemotherapy.
Huang ZH; Hua D; Du X
Cancer Chemother Pharmacol; 2009 Oct; 64(5):1001-7. PubMed ID: 19247656
[TBL] [Abstract][Full Text] [Related]
13. [Polymorphism of methylenetetrahydrofolate reductase and sensitivity of stomach cancer to fluoropyrimidine-based chemotherapy].
Gao CM; Lu JW; Toshiro T; Wu JZ; Cao HX; Chen HQ; Feng JF; Kazuo T
Zhonghua Liu Xing Bing Xue Za Zhi; 2004 Dec; 25(12):1054-8. PubMed ID: 15769364
[TBL] [Abstract][Full Text] [Related]
14. mdr-1 single nucleotide polymorphisms in ovarian cancer tissue: G2677T/A correlates with response to paclitaxel chemotherapy.
Gréen H; Söderkvist P; Rosenberg P; Horvath G; Peterson C
Clin Cancer Res; 2006 Feb; 12(3 Pt 1):854-9. PubMed ID: 16467099
[TBL] [Abstract][Full Text] [Related]
15. MDR1 single nucleotide polymorphisms predict response to vinorelbine-based chemotherapy in patients with non-small cell lung cancer.
Pan JH; Han JX; Wu JM; Sheng LJ; Huang HN; Yu QZ
Respiration; 2008; 75(4):380-5. PubMed ID: 17851225
[TBL] [Abstract][Full Text] [Related]
16. Association of the ABCB1 gene polymorphisms 2677G>T/A and 3435C>T with clinical outcomes of paclitaxel monotherapy in metastatic breast cancer patients.
Chang H; Rha SY; Jeung HC; Im CK; Ahn JB; Kwon WS; Yoo NC; Roh JK; Chung HC
Ann Oncol; 2009 Feb; 20(2):272-7. PubMed ID: 18836089
[TBL] [Abstract][Full Text] [Related]
17. No influence of 3435C>T ABCB1 (MDR1) gene polymorphism on risk of adult acute myeloid leukemia and P-glycoprotein expression in blast cells.
Jamroziak K; Balcerczak E; Cebula B; Janus A; Mirowski M; Robak T
Ther Drug Monit; 2006 Oct; 28(5):707-11. PubMed ID: 17038891
[TBL] [Abstract][Full Text] [Related]
18. Genetic polymorphisms in the ABCB1 gene and the effects of fentanyl in Koreans.
Park HJ; Shinn HK; Ryu SH; Lee HS; Park CS; Kang JH
Clin Pharmacol Ther; 2007 Apr; 81(4):539-46. PubMed ID: 17192767
[TBL] [Abstract][Full Text] [Related]
19. Influence of ABCB1 genetic variants in breast cancer treatment outcomes.
Chaturvedi P; Tulsyan S; Agarwal G; Lal P; Agarwal S; Mittal RD; Mittal B
Cancer Epidemiol; 2013 Oct; 37(5):754-61. PubMed ID: 23707158
[TBL] [Abstract][Full Text] [Related]
20. ABCB1 genotype of the donor but not of the recipient is a major risk factor for cyclosporine-related nephrotoxicity after renal transplantation.
Hauser IA; Schaeffeler E; Gauer S; Scheuermann EH; Wegner B; Gossmann J; Ackermann H; Seidl C; Hocher B; Zanger UM; Geiger H; Eichelbaum M; Schwab M
J Am Soc Nephrol; 2005 May; 16(5):1501-11. PubMed ID: 15772250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
